
Loading, please wait...

Loading, please wait...

The Chhatua nutrition programme safety has come under intense scrutiny by the National Human Rights Commission (NHRC). Specifically, the NHRC recently requested an Action Taken Report from the Odisha government. This follows serious allegations regarding the distribution of supplementary food to vulnerable groups without proper safety testing. Consequently, authorities must now explain how this protein-rich mixture reaches infants and mothers despite significant laboratory delays.
Additionally, human rights activists filed a detailed complaint highlighting a severe mismatch in food safety timelines. Currently, around 8,000 self-help groups distribute \"chhatua\" to pregnant women and infants across Odisha. However, the State Food Testing Laboratory often takes up to 60 days to issue quality reports. Since the product only has a 30-day shelf life, beneficiaries usually consume the food before results arrive. Therefore, the current testing process fails to ensure the biological safety of these crucial nutritional supplements.
Furthermore, the complaint flags potential violations of Food Safety and Standards Authority of India (FSSAI) norms. These national regulations mandate scientific validation before any food distribution occurs. Moreover, logistical delays in remote tribal districts like Koraput further reduce the safe consumption window for the local community. Thus, the NHRC has directed the Chief Secretary to provide a response within four weeks. The Commission might recommend a \"test-first, distribute-later\" protocol to prevent future health risks. Establishing decentralized testing laboratories in southern and western Odisha could also resolve these timing issues.
Q1: Why is the NHRC investigating the Chhatua program?
The NHRC is investigating allegations that the Odisha government distributes supplementary food without timely safety testing, potentially risking the health of children and mothers.
Q2: What is the primary issue with the current testing timeline?
The primary issue is that laboratory testing takes up to 60 days, while the shelf life of the \"chhatua\" mixture is only 30 days, leading to results arriving after consumption.
Q3: What are the suggested interim measures for the program?
The complainant suggested either halting the distribution of untested food or providing direct benefit transfers to beneficiaries for purchasing certified products from the market.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


NHRC seeks an Action Taken Report from Odisha regarding the distribution of untested Chhatua to children and mothers under the nutrition program....
6 months ago

Co-administering antiseizure medications and DOACs frequently causes pharmacokinetic interactions, subtherapeutic drug levels, and thromboembolic failures. This review highlights enzyme induction risks, unpredictable outcomes with levetiracetam, and the vital role of therapeutic drug monitoring.
Today

Demanding exhaustive hormonal profiling can inadvertently discourage clinical studies involving females. Methodological standards must align with the specific scientific question to expand, not restrict, equitable evidence for women.
Today

An elderly man with partially repaired Tetralogy of Fallot presented with STEMI caused by coronary embolism rather than atherosclerosis. Successful treatment with sustained mechanical aspiration thrombectomy underscores the vital need for high clinical vigilance in adult congenital heart disease.
Today

A comparative review of tension band wiring and intramedullary screw fixation in thumb metacarpophalangeal arthrodesis, evaluating union rates, hardware complications, and clinical outcomes.
Today

Following regulatory scrutiny from FSSAI regarding promotional representations and lean muscle preservation claims, Dr. Reddy's Laboratories and Nestlé Health Science are currently reviewing the branding and marketing strategy for their joint nutritional supplement Celevida GLP+.
Today